Wall Street Zen Downgrades Oscar Health (NYSE:OSCR) to Sell

Oscar Health (NYSE:OSCR) was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a report issued on Saturday.

Several other equities analysts have also recently issued reports on OSCR. Barclays boosted their price target on Oscar Health from $11.00 to $13.00 and gave the company an “underweight” rating in a research report on Monday, November 10th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Oscar Health in a report on Wednesday, October 8th. The Goldman Sachs Group started coverage on shares of Oscar Health in a research report on Tuesday, October 14th. They issued a “neutral” rating and a $17.00 price target on the stock. Wells Fargo & Company dropped their price objective on Oscar Health from $14.00 to $11.00 and set an “underweight” rating for the company in a research report on Thursday, November 13th. Finally, Zacks Research upgraded Oscar Health from a “strong sell” rating to a “hold” rating in a report on Monday, October 13th. One equities research analyst has rated the stock with a Buy rating, five have given a Hold rating and five have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Reduce” and an average target price of $14.86.

Oscar Health Stock Performance

Shares of NYSE OSCR opened at $16.77 on Friday. The company has a 50 day simple moving average of $18.03 and a two-hundred day simple moving average of $16.94. The stock has a market cap of $4.44 billion, a price-to-earnings ratio of -14.97 and a beta of 1.88. The company has a current ratio of 0.92, a quick ratio of 0.92 and a debt-to-equity ratio of 0.67. Oscar Health has a 12 month low of $11.20 and a 12 month high of $23.80.

Oscar Health (NYSE:OSCR) last announced its earnings results on Thursday, November 6th. The company reported ($0.53) EPS for the quarter, beating analysts’ consensus estimates of ($0.55) by $0.02. The business had revenue of $2.93 billion during the quarter, compared to analysts’ expectations of $3.09 billion. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.The business’s revenue was up 23.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned ($0.22) earnings per share. As a group, analysts predict that Oscar Health will post 0.69 earnings per share for the current year.

Insider Activity at Oscar Health

In related news, CFO Richard Scott Blackley sold 25,135 shares of the company’s stock in a transaction dated Tuesday, December 2nd. The shares were sold at an average price of $16.59, for a total value of $416,989.65. Following the sale, the chief financial officer owned 1,351,034 shares of the company’s stock, valued at $22,413,654.06. The trade was a 1.83% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Adam Mcananey sold 1,852 shares of the company’s stock in a transaction dated Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total transaction of $30,724.68. Following the transaction, the insider owned 179,241 shares in the company, valued at approximately $2,973,608.19. This trade represents a 1.02% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 739,472 shares of company stock worth $12,616,880 in the last 90 days. 24.39% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Farther Finance Advisors LLC raised its stake in Oscar Health by 4,420.7% in the third quarter. Farther Finance Advisors LLC now owns 1,311 shares of the company’s stock valued at $25,000 after buying an additional 1,282 shares during the period. LRI Investments LLC increased its position in Oscar Health by 377.9% during the 2nd quarter. LRI Investments LLC now owns 1,233 shares of the company’s stock worth $26,000 after purchasing an additional 975 shares in the last quarter. Jones Financial Companies Lllp grew its holdings in shares of Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after purchasing an additional 2,242 shares during the last quarter. Strs Ohio acquired a new stake in Oscar Health in the first quarter valued at $30,000. Finally, Atlantic Union Bankshares Corp bought a new position in Oscar Health during the second quarter worth $33,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.